Russian Journal of Bioorganic Chemistry

, Volume 44, Issue 2, pp 173–177 | Cite as

Blood Plasma Pseudocholinesterase as a Potential Biomarker of Autoimmune Diseases

  • D. I. Kozlova
  • A. V. Popov
  • D. S. Vasilyev
  • E. D. Suglobova
  • V. M. Markovskiy
Article
  • 5 Downloads

Abstract

We studied the blood plasma butyrylcholinesterase (BChE, pseudocholinesterase) activity as a potential marker for differentiating such autoimmune pathologies as type 1 diabetes mellitus (DM1), autoimmune thyroiditis (AIT) and rheumatoid arthritis (RA) from diseases having similar symptoms but different etiology. The blood plasma pseudocholinesterase activity was analyzed for patients with different types of diabetes mellitus. We showed its fivefold increase in DM1 compared to the control group, while in the second type of diabetes, which is metabolic pathology, it decreases two times. It was demonstrated that the activity of blood plasma BChE in patients with AIT and RA also increased fivefold compared to the group of patients without autoimmune disorders. Thus, the butyrylcholinesterase activity increases in diseases of an autoimmune nature, whereas in metabolic pathology it has the tendency to decrease; it indicates the adequacy of the selected criterion for the further development of a screening test-system that would allow differentiation of autoimmune diseases from the diseases of another origin, but with similar symptoms.

Keywords

butyrylcholinesterase activity diabetes mellitus autoimmune thyroiditis rheumatoid arthritis blood plasma biomarker 

Abbreviations

AD

autoimmune diseases

AIT

autoimmune thyroiditis

DM1

type 1 diabetes mellitus

DM2

type 2 diabetes mellitus

CG

control group of patients without autoimmune and metabolic pathologies

RA

rheumatoid arthritis

BChE

butyrylcholinesterase, pseudocholinesterase

DTNB

5,5'-dithiobis( 2-nitrobenzoid acid)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Assayag, E.B., Tsarfaty, S.S., Ofek, K., Soreq, L., Irena, B., Shopin, L., Berg, R.M., Berliner, S., Shapira, I., Bornstein, N.M., and Soreq, H., Mol. Med., 2010, vol. 16, nos. 7–8, pp. 178–286.Google Scholar
  2. 2.
    Santarpia, L., Grandone, I., Contaldo, F., and Pasanisi, F., Cachexia Sarcopenia Muscle, 2013, vol. 3, pp. 31–39.CrossRefGoogle Scholar
  3. 3.
    Bonham, J.R., Gowenlock, H., and Timothy, A.D., Clin. Chim. Acta, 1981, vol. 115, pp. 163–170.CrossRefPubMedGoogle Scholar
  4. 4.
    Zhuravin, I.A., Nalivaeva, N.N., Kozlova, D.I., Kochkina, E.G., Fedorova, Ya.B., and Gavrilova, S.I., Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 2015, no. 11, pp. 77–85.Google Scholar
  5. 5.
    Lerner, A., Jeremias, P., and Matthias, T., Int. J. Celiac Dis., 2015, vol. 3, pp. 151–155.CrossRefGoogle Scholar
  6. 6.
    Kozlova, D.I. and Popov, A.V., Butyrylcholinesterase as a potential biomarker of autoimmune diseases, in Mezhdunarodnaya nauchnaya konferentsiya po bioorganicheskoi khimii “XII Chteniya pamyati akademika Yuriya Anatol’evicha Ovchinnikova” i VIII Rossiiskii simpozium “Belki i peptidy”: tezisy dokl. Mezhdunar. konf. (Moskva, IBKh RAN, 18–22 sent. 2017 g.) (Int. Sci. Conf. on Bioorg. Chem. “XII Yu.A. Ovchinnikov Memorial Lecture” and VIII All-Russia Symp. “Proteins and Peptides:” Abstr. Int. Conf.), Moscow: Izd. Pero, 2017, p. 74.Google Scholar
  7. 7.
    Larina, A.A. and Troshina, E.A., Probl. Endokrinol., 2013, no. 1, pp. 35–43.CrossRefGoogle Scholar
  8. 8.
    Pohanka, M., Int. J. Mol. Sci., 2014, pp. P. 9809–9825.Google Scholar
  9. 9.
    Darvesh, S., LeBlanc, A.M., Macdonald, I.R., Reid, G.A., Bhan, V., Macaulay, R.J., and Fisk, J.D., Chem.-Biol. Interac., 2010, vol. 187, pp. 425–431.CrossRefGoogle Scholar
  10. 10.
    Witter, R.F., Arch. Environ. Health: Int. J., 1963, vol. 6, pp. 537–563.CrossRefGoogle Scholar
  11. 11.
    Bradford, M.M., Anal. Biochem., 1976, vol. 72, pp. 248–254.CrossRefPubMedGoogle Scholar
  12. 12.
    Ellman, G.L., Courtney, K.D., Andreas, V.J., and Featherstone, R.M., Biochem. Pharmacol., 1961, vol. 7, pp. 88–95.CrossRefPubMedGoogle Scholar
  13. 13.
    Nalivaeva, N.N., Makova, N.Z., Kochkina, E.G., Dzhon, D., Arutyunov, V.A., Kozina, L.S., Arutyunyan, A.V., and Zhuravin, I.A., Neirokhimiya, 2011, vol. 28, no. 3, pp. 200–207.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • D. I. Kozlova
    • 1
    • 2
  • A. V. Popov
    • 1
  • D. S. Vasilyev
    • 1
    • 2
  • E. D. Suglobova
    • 1
    • 3
  • V. M. Markovskiy
    • 1
  1. 1.ABRIS+ Ltd.St. PetersburgRussia
  2. 2.Sechenov Institute of Evolutionary Physiology and BiochemistryRussian Academy of SciencesSt. PetersburgRussia
  3. 3.Pavlov First St. Petersburg State Medical UniversitySt. PetersburgRussia

Personalised recommendations